Sewer sampling, the authors say, could be expanded to track other infectious diseases such as H5N1 avian flu or mpox or to detect unexpected pathogens.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
Southeast Asia and the Western Pacific saw modest rises, but cases are down worldwide.
An observational study published this week in eClinicalMedicine suggests that COVID-19–related acute kidney injury (AKI) is tied to a greater risk of death, and that severe AKI may lead to poor recovery of kidney function.
A study of US patients aged 0 to 20 years hospitalized for COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in 2020 and 2021 shows that 22% had a neurologic condition, including 9% with life-threatening illness.
Myocarditis and pericarditis are rare after COVID vaccination, but rates were twofold to threefold higher after receipt of the second dose of the Moderna vaccine than after the Pfizer version.
Those taking Paxlovid had a 25% lower risk of developing 10 of 12 long-COVID conditions.
Selective serotonin reuptake inhibitors (SSRIs), the most commonly used class of antidepressants in the United States, don't appear to prevent severe COVID-19 or death among outpatients, according to a study presented this week at the American Heart Association's Scientific Sessions in Chicago.
Muliple respiratory viruses are already straining health systems, with children among the hardest hit groups.
Neutralizing antibodies were about fourfold higher than with Pfizer's original COVID vaccine.
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
A study of hospitalized COVID-19 patients in Michigan found that procalcitonin (PCT) trends were associated with the decision to initiate antibiotics and duration of treatment, independent of bacterial pneumonia (bPNA) status, researchers reported today in Infection Control & Hospital Epidemiology.
